miR-337 can be a key negative regulator in melanoma

Cancer Biol Ther. 2017 Jun 3;18(6):392-399. doi: 10.1080/15384047.2017.1323581. Epub 2017 May 12.

Abstract

Incidence of melanoma is increasing annually worldwide. There remains a lack of suitable treatment methods which can significantly improve the 5-year survival rates of patients. It is established that micro RNAs (miRNAs) have important roles in the diagnosis and treatment of cancer. MiR-337 had been reported to regulate the development of variety of cancers, as a cancer suppressive factor. In our research we found that miR-337 had a lower expression in melanoma than adjacent tissues. The patients who had a lower miR-337 also got a worse survival. MiR-337 could target STAT3 to regulate the occurrence and development of melanoma. In summary, our findings suggest that the miR-337/STAT3 axis may serve as a potential target for the treatment of melanoma.

Keywords: Melanoma; STAT3; metastasis; prognosis; proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions
  • Adult
  • Base Sequence
  • Binding Sites
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Gene Expression Regulation, Neoplastic
  • HEK293 Cells
  • Humans
  • Melanoma / metabolism*
  • Melanoma / mortality
  • Melanoma / pathology
  • MicroRNAs / physiology*
  • Middle Aged
  • RNA Interference
  • STAT3 Transcription Factor / genetics
  • STAT3 Transcription Factor / metabolism
  • Skin Neoplasms / metabolism*
  • Skin Neoplasms / mortality
  • Skin Neoplasms / pathology

Substances

  • 3' Untranslated Regions
  • MicroRNAs
  • Mirn337 microRNA, human
  • STAT3 Transcription Factor
  • STAT3 protein, human